Reta peptide is retatrutide, an experimental triple-agonist drug targeting GLP-1, GIP, and glucagon. Learn what it does, how it works, and its FDA status.
Reta peptide is the nickname for retatrutide, an experimental drug that activates three hormone receptors at once: GLP-1, GIP, and glucagon. It is a lab-made peptide, not a steroid, and it is not approved by the FDA for human use in the United States. Researchers are studying it for weight loss and metabolic effects, but it remains an investigational compound found only in clinical trials and research settings.
What Does "Reta" Stand For?
"Reta" is not an official medical term and it is not an acronym. It is shorthand that grew out of the drug's generic name, retatrutide, and it spread through fitness forums, Reddit threads, and peptide vendor listings. The reta meaning in everyday use is simply "retatrutide."
Spanish-language searchers often type que es reta, which asks the same question in another language. The answer does not change: reta is a shortened name for one specific investigational peptide.
Retatrutide is a single-chain peptide engineered in a laboratory to imitate and combine the actions of three natural hormones. It is not a vitamin, a dietary supplement, or a hormone your body produces on its own.
Is Reta a GLP-1, a GLP-3, or a Triple Agonist?
Reta is a triple agonist, which means it binds to three different receptors rather than one. The three targets are GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and the glucagon receptor.
There is no receptor called "GLP-3." The common search phrase is reta a glp-3 comes from internet shorthand that treats a triple-agonist design as a "third generation" of GLP-based drugs. Whether you see reta glp 3 peptide, reta 3, or glp 3 reta, people are describing the same compound.
| Receptor | Normal role in the body | Reta's activity |
|---|---|---|
| GLP-1 | Slows stomach emptying, reduces appetite, supports insulin release | Agonist (activates) |
| GIP | Influences insulin secretion and fat metabolism | Agonist (activates) |
| Glucagon receptor | Raises energy expenditure and supports fat breakdown | Agonist (activates) |
Reta peptide is a triple agonist that targets GLP-1, GIP, and the glucagon receptor, so the term GLP-3 is internet shorthand rather than a real receptor name.
Is Reta a Steroid or a Supplement?
No. Reta is a peptide, and peptides are short chains of amino acids, while anabolic steroids are synthetic versions of testosterone. They are chemically unrelated, they work through completely different pathways, and they carry different risks.
Reta is also not a dietary supplement. It is an investigational drug candidate, even though some gray-market sellers file it under the loose category of what is a research peptide. Product labels that call it a supplement or a "reta steroid" are inaccurate.
What Does Reta Peptide Do?
In clinical trials, retatrutide has produced larger average weight loss than any approved GLP-1 or dual-agonist drug tested so far. Its effects appear to come from two directions at once: it lowers how much people eat, and it may raise how many calories the body burns.
Appetite and food intake
GLP-1 and GIP activity slows digestion and signals fullness to the brain. Trial participants commonly report eating less and feeling satisfied sooner. People in bodybuilding communities often ask what is reta in fitness contexts for exactly this reason.
Energy expenditure and metabolism
The glucagon component is what separates retatrutide from older weight-loss drugs. Glucagon receptor activation raises resting energy expenditure, which is why so many people ask whether reta burns fat or just suppresses appetite.
Retatrutide appears to lower body weight through both reduced calorie intake and increased energy expenditure, while GLP-1-only drugs work mainly through appetite suppression.
How Reta Compares to Other Incretin Drugs
| Drug | Receptors targeted | FDA status | How it is taken |
|---|---|---|---|
| Semaglutide | GLP-1 only | Approved | Injection or oral tablet |
| Tirzepatide | GLP-1 + GIP | Approved | Injection |
| Retatrutide (reta) | GLP-1 + GIP + glucagon | Not approved; investigational | Injection (research only) |
All three are injectable peptides studied for weight management, but only two have completed large phase 3 trials and have known safety profiles. Retatrutide is still being evaluated, so its benefits and risks are not fully mapped.
Reta and Other Research Peptides
Reta sits in the same online marketplace as many unrelated peptides, which creates a lot of confusion. Someone researching what is cjc-1295 ipamorelin used for is looking at growth-hormone signaling, not appetite or metabolism, and what is ipamorelin peptide describes a compound that works on a completely different pathway.
Likewise, people who read about bac water what is it are usually just learning how peptide powders are reconstituted. Sharing a supply chain does not make two peptides related in how they work.
Legal Status and Safety in the United States
Retatrutide has not been approved by the FDA, and it is not legal to buy for personal use. Products sold online as reta are unapproved research chemicals that may be mislabeled, underdosed, or contaminated.
- Reported side effects in trials include nausea, vomiting, diarrhea, constipation, and injection-site reactions.
- Researchers have also observed increases in resting heart rate and, in some cases, gallbladder problems.
- Anyone with a history of pancreatitis, thyroid cancer, or gallbladder disease should speak with a healthcare professional before considering any incretin-based drug.
- Long-term safety data for retatrutide does not yet exist, and what happens after stopping the drug is not fully understood.
Reta peptide is not FDA-approved, and products sold online as retatrutide are unapproved research chemicals that are not intended for human use.
If you are considering a weight-management medication, the safest path is to talk with a licensed healthcare professional about approved options and your individual health history.
Frequently Asked Questions
Is reta a GLP-1 or a GLP-3?
Reta is neither a single GLP-1 drug nor a real "GLP-3" drug. Retatrutide is a triple agonist that activates three receptors: GLP-1, GIP, and the glucagon receptor. There is no such receptor as GLP-3; that term is informal internet shorthand for a triple-agonist peptide.
Is reta peptide a steroid?
No, reta is a peptide, which is a short chain of amino acids, while anabolic steroids are synthetic testosterone-like compounds. The two are chemically different and work through unrelated biological pathways. Reta is also not a dietary supplement, despite how some vendors label it.
What is reta peptide used for?
Retatrutide is being studied for weight loss and metabolic health in clinical trials, where it has produced significant average weight reduction. It is designed to reduce appetite and increase energy expenditure at the same time. Reta is not FDA-approved, so it is not available as a legal prescription for human use in the United States.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.